TY - JOUR
T1 - When and How To Use Endoscopic Tattooing in the Colon: An International Delphi Agreement
AU - Medina-Prado, Lucía
AU - Hassan, Cesare
AU - Dekker, Evelien
AU - Bisschops, Raf
AU - Alfieri, Sergio
AU - Bhandari, Pradeep
AU - Bourke, Michael J.
AU - Bravo, Raquel
AU - Bustamante-Balen, Marco
AU - Dominitz, Jason
AU - Ferlitsch, Monika
AU - Fockens, Paul
AU - van Leerdam, Monique
AU - Lieberman, David
AU - Herráiz, Maite
AU - Kahi, Charles
AU - Kaminski, Michal
AU - Matsuda, Takahisa
AU - Moss, Alan
AU - Pellisé, Maria
AU - Pohl, Heiko
AU - Rees, Colin
AU - Rex, Douglas K.
AU - Romero-Simó, Manuel
AU - Rutter, Matthew D.
AU - Sharma, Prateek
AU - Shaukat, Aasma
AU - Thomas-Gibson, Siwan
AU - Valori, Roland
AU - Jover, Rodrigo
N1 - Funding Information:
Lucia Medina-Prado, Researcher (Visualization: Equal; Writing ? original draft: Equal; Writing ? review & editing: Lead), Cesare Hassan (Conceptualization: Lead; Data curation: Lead; Investigation: Lead; Methodology: Lead; Project administration: Lead), Evelien Dekker (Conceptualization: Lead; Data curation: Lead; Formal analysis: Lead; Investigation: Lead; Methodology: Lead; Project administration: Lead; Validation: Equal), Raf Bisschops (Conceptualization: Lead; Data curation: Lead; Formal analysis: Lead; Investigation: Lead; Methodology: Lead; Project administration: Lead; Supervision: Lead; Validation: Equal), Sergio Alfieri (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Pradeep Bhandari (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Michael J.Bourke (Data curation: Equal; Investigation: Equal; Methodology: Equal; Validation: Equal; Visualization: Equal), Raquel Bravo (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Marco Bustamante-Balen (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Jason Dominitz (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Monika Ferlitsch (Data curation: Equal; Investigation: Equal; Methodology: Equal; Validation: Equal; Visualization: Equal), Paul Fockens (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Monique van Leerdam (Data curation: Equal; Formal analysis: Equal; Investigation: Equal; Methodology: Equal; Validation: Equal; Visualization: Equal), David Lieberman (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Maite Herr?iz (Data curation: Equal; Investigation: Equal; Methodology: Equal; Validation: Equal; Visualization: Equal), Charles Kahi (Data curation: Equal; Formal analysis: Equal; Investigation: Equal; Methodology: Equal; Validation: Equal; Visualization: Equal), Michal Kaminski (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Takahisa Matsuda (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Alan Moss (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Maria Pellis? (Data curation: Equal; Formal analysis: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Heiko Pohl (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Colin Rees (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Lead), Douglas K. Rex (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Manuel Romero-Sim? (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Matthew D. Rutter (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Prateek Sharma (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Aasma Shaukat (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Siwan Thomas-Gibson (Data curation: Equal; Investigation: Equal; Validation: Equal; Visualization: Equal), Roland Valori (Data curation: Equal; Investigation: Equal; Supervision: Equal; Validation: Equal), Rodrigo Jover (Conceptualization: Lead; Data curation: Lead; Formal analysis: Lead; Investigation: Lead; Methodology: Lead; Project administration: Lead; Supervision: Lead; Validation: Equal; Visualization: Equal; Writing ? original draft: Equal; Writing ? review & editing: Supporting) Conflicts of interest These authors disclose the following: Rodrigo Jover and Evelien Dekker have received honorarium for consultancy and speaker's fee from GI Supply; Cesare Hassan and Raf Bisschops have received honorarium for consultancy from GI Supply; and Heiko Pohl has received research grants from Steris and Cosmo Pharmaceuticals. The remaining authors disclose no conflicts.
Publisher Copyright:
© 2021 AGA Institute
PY - 2021/5/1
Y1 - 2021/5/1
N2 - Background & Aims: There is a lack of clinical studies to establish indications and methodology for tattooing, therefore technique and practice of tattooing is very variable. We aimed to establish a consensus on the indications and appropriate techniques for colonic tattoo through a modified Delphi process. Methods: The baseline questionnaire was classified into 3 areas: where tattooing should not be used (1 domain, 6 questions), where tattooing should be used (4 domains, 20 questions), and how to perform tattooing (1 domain 20 questions). A total of 29 experts participated in the 3 rounds of the Delphi process. Results: A total of 15 statements were approved. The statements that achieved the highest agreement were as follows: tattooing should always be used after endoscopic resection of a lesion with suspicion of submucosal invasion (agreement score, 4.59; degree of consensus, 97%). For a colorectal lesion that is left in situ but considered suitable for endoscopic resection, tattooing may be used if the lesion is considered difficult to detect at a subsequent endoscopy (agreement score, 4.62; degree of consensus, 100%). A tattoo should never be injected directly into or underneath a lesion that might be removed endoscopically at a later point in time (agreement score, 4.79; degree of consensus, 97%). Details of the tattoo injection should be stated clearly in the endoscopy report (agreement score, 4.76; degree of consensus, 100%). Conclusions: This expert consensus has developed different statements about where tattooing should not be used, when it should be used, and how that should be done.
AB - Background & Aims: There is a lack of clinical studies to establish indications and methodology for tattooing, therefore technique and practice of tattooing is very variable. We aimed to establish a consensus on the indications and appropriate techniques for colonic tattoo through a modified Delphi process. Methods: The baseline questionnaire was classified into 3 areas: where tattooing should not be used (1 domain, 6 questions), where tattooing should be used (4 domains, 20 questions), and how to perform tattooing (1 domain 20 questions). A total of 29 experts participated in the 3 rounds of the Delphi process. Results: A total of 15 statements were approved. The statements that achieved the highest agreement were as follows: tattooing should always be used after endoscopic resection of a lesion with suspicion of submucosal invasion (agreement score, 4.59; degree of consensus, 97%). For a colorectal lesion that is left in situ but considered suitable for endoscopic resection, tattooing may be used if the lesion is considered difficult to detect at a subsequent endoscopy (agreement score, 4.62; degree of consensus, 100%). A tattoo should never be injected directly into or underneath a lesion that might be removed endoscopically at a later point in time (agreement score, 4.79; degree of consensus, 97%). Details of the tattoo injection should be stated clearly in the endoscopy report (agreement score, 4.76; degree of consensus, 100%). Conclusions: This expert consensus has developed different statements about where tattooing should not be used, when it should be used, and how that should be done.
UR - https://www.scopus.com/pages/publications/85103967837
U2 - 10.1016/j.cgh.2021.01.024
DO - 10.1016/j.cgh.2021.01.024
M3 - Article
C2 - 33493699
SN - 1542-3565
VL - 19
SP - 1038
EP - 1050
JO - Clinical gastroenterology and hepatology
JF - Clinical gastroenterology and hepatology
IS - 5
ER -